Literature DB >> 3753203

MAV-2-O replicates at a reduced rate in cells from the osteopetrosis resistant G-B1 chicken.

J Böni, M Böni-Schnetzler, R M Frank, R M Franklin.   

Abstract

The replication of the avian osteopetrosis virus MAV-2-O was compared in chick embryo fibroblasts from two strains of chicken. These were G-B1 which is relatively resistant to MAV-2-O and CB which is susceptible. The production of MAV-2-O was delayed in G-B1 cells (compared with CB cells). The same result was observed after infection with Rous sarcoma viruses of subgroups B, C, and D. In addition, the transforming viruses induced foci on G-B1 fibroblasts 24 to 48 hours later than on CB fibroblasts. In G-B1 cells there was also a delayed kinetics of intracellular viral RNA production. Integrated and linear unintegrated MAV-2-O DNA species were also present in lower amounts in G-B1 than in CB fibroblasts at 3 days postinfection. In vivo studies confirmed the in vitro situation. There was a marked difference in the amount of virus present in the osteoid bone matrix and the osteocytic lacunae of osteopetrotic bones from susceptible and G-B1 chickens. In contrast to the bone lesions from susceptible animals, budding virus particles were not detectable in lesions from G-B1 chickens. There was no difference in the amount of virus in osteopetrotic and non-osteopetrotic bone of susceptible chickens suggesting that virus replication alone is not sufficient for induction of osteopetrosis and that an additional specific virus-cell interaction is required. The relative resistance of strain G-B1 may therefore, be a consequence of a reduced frequency of this interaction. Its basis may be the lower amount of integrated, as well as unintegrated, viral DNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753203     DOI: 10.1007/bf01316726

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Avian leukosis virus-induced osteopetrosis is associated with the persistent synthesis of viral DNA.

Authors:  H L Robinson; B D Miles
Journal:  Virology       Date:  1985-02       Impact factor: 3.616

2.  Oncogenicity of non-transforming mutants of avian sarcoma viruses.

Authors:  P M Biggs; B S Milne; T Graf; H Bauer
Journal:  J Gen Virol       Date:  1973-03       Impact factor: 3.891

3.  The oncogenic effects of nontransforming viruses from avian myeloblastosis virus.

Authors:  R E Smith; C Moscovici
Journal:  Cancer Res       Date:  1969-07       Impact factor: 12.701

4.  Identification of plaque isolates of an avian retrovirus causing rapid and slow onset osteopetrosis.

Authors:  R E Smith; J H Morgan
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

5.  Organization of chicken DNA sequences homologous to the transforming gene of avian myeloblastosis virus. II. Isolation and characterization of lambda proto-amv DNA recombinant clones from a library of leukemic chicken DNA.

Authors:  B Perbal; J M Cline; R L Hillyard; M A Baluda
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

6.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

7.  Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome.

Authors:  R Nusse; H E Varmus
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

8.  Cell killing by avian leukosis viruses.

Authors:  S K Weller; H M Temin
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

9.  Chicken strain G-B1 exhibits a relative resistance to avian osteopetrosis.

Authors:  J Böni; M Böni-Schnetzler; O Vainio; R M Franklin
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  Independent recombination between avian leukosis virus terminal sequences and host DNA in virus-induced proliferative disease.

Authors:  P Neiman; K Beemon; J A Luce
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.